Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Pr ...
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.387
https://www.valueinhealthjournal.com/article/S1098-3015(15)02463-8/fulltext
Title :
Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Pr ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02463-8&doi=10.1016/j.jval.2015.09.387
First page :
A843
Section Title :
Research Podium Presentations - Session 1
Open access? :
No
Section Order :
2612